have found miR-7 is involved in regulating the EGFR signaling pathway by down-regulating the expression of EGFR and RAF-1, which could inhibit CRC cells proliferation and reverse cetuximab resistance in CRC patients with mutant KRAS (41). The gene discussed is KRAS; the disease is colorectal carcinoma.